Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five years' experience

1. Five years' experience in the use of beclomethasone dipropionate aerosol (BDA) in the treatment of 315 patients with upper respiratory tract allergy is reviewed. 2. A total of 223 patients with perennial rhinitis was treated. In 23, where the nasal allergy had recurred after oral corticoster...

Full description

Saved in:
Bibliographic Details
Published in:British journal of clinical pharmacology 1977, Vol.4 (S3), p.283S-286S
Main Authors: Brown, HM, Storey, G, Jackson, FA
Format: Article
Language:English
Subjects:
Aerosols
Asthma - drug therapy
Beclomethasone - administration & dosage
Beclomethasone - therapeutic use
Chronic Disease
Clinical Trials as Topic
Humans
Rhinitis - drug therapy
Seasons
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:1. Five years' experience in the use of beclomethasone dipropionate aerosol (BDA) in the treatment of 315 patients with upper respiratory tract allergy is reviewed. 2. A total of 223 patients with perennial rhinitis was treated. In 23, where the nasal allergy had recurred after oral corticosteroid therapy for asthma was withdrawn, BDA was effective in 69% of cases. A similar success rate (68%) was recorded in 169 patients suffering from perennial allergic rhinitis alone, but a satisfactory response was observed in only 45% of 31 patients with nasal polypi. 3. In 92 patients with seasonal allergic rhinitis freedom from symptoms was achieved in 80%. 4. A total of approximately 534 patient‐years of treatment has been recorded without any evidence of side‐effects either clinically or on nasal biopsy.
ISSN:0306-5251
1365-2125
DOI:10.1111/j.1365-2125.1977.tb04522.x